InvestorsHub Logo
Followers 62
Posts 1712
Boards Moderated 0
Alias Born 08/08/2005

Re: Protector post# 320239

Friday, 12/08/2017 9:25:30 AM

Friday, December 08, 2017 9:25:30 AM

Post# of 345759
Cell Design! AVID, this year added a new arm for "cell design". So AVID itself may become a target along with Peregrine's anti-PS technologies, mAbs etc.

CAR T should definitely be on our radar, as well as the anti-PDxx immunotherapy combinations.

Safety and increased treatment footprints are strong factors for immunotherapy BPs.

IMO

sunstar
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News